Application of cytokine intervention for improved radio-antibody dose delivery

International Journal of Cancer

Volumn 72, Issue 1, 1997, Pages 166-173

  Blumenthal, Rosalyn D ^a,b   Sharkey, Robert M ^a   Haywood, Lemuel ^a   Behr, Thomas ^a   Goldenberg, David M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^b GSCC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; INTERLEUKIN 1; IODINE 131; RHENIUM 188; YTTRIUM 90;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; FEMALE; HEMATOPOIETIC TISSUE; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL; THROMBOCYTOPENIA; WEIGHT;

ANIMALS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; INTERLEUKIN-1; IODINE RADIOISOTOPES; LEUKOCYTE COUNT; MICE; MICE, INBRED BALB C; NEUTROPENIA; RADIOIMMUNOTHERAPY; RHENIUM; THROMBOCYTOPENIA; YTTRIUM RADIOISOTOPES;

EID: 0030835438     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970703)72:1<166::AID-IJC24>3.0.CO;2-G     Document Type: Article

References (45)

1. ANTMAN, K.S., GRIFFIN, J.D., ELIAS, A., SOCINSKI, M.A., RYAN, L., CANNISTRA, S.A., OETTE, D., WHITLEY, M., FREI, E. and SCHIPPNER, L.E., Effect of recombinant human granulocyte-macrophage colony stimulating factor on chemotherapy-induced myelosuppression. New Engl. J. Med., 319, 593-598 (1988).
2. APPLEBAUM, F.R., BADGER, C.C., DEEG, H.J., NELP, W.B. and STARB, R., Use of iodine-131-labeled anti-immune response associated monoclonal antibody as a preoperative regimen prior to bone marrow transplantation: initial dosimetry. Nat. Cancer Inst. Monogr., 3, 67-71 (1987).
3. BEHR, T.M., SHARKEY, R.M., JUWEID, M.E., DUNN, R.M., VAGG, R.C., YING, Z., ZHANG, C.H., SWAYNE, L.C., VARDI, Y., SIEGEL, J.A. and GOLDENBERG, D.M., Phase I/II clinical radioimmunotherapy with an I-131-anti-CEA murine IgG monoclonal antibody. J. nucl. Med. (1997) (In press).
4. BLUMENTHAL, R.D., SHARKEY, R.M., FORMAN, D., WONG, G. and GOLDENBERG, D.M., Cytokine intervention permits dose escalation of radioantibody: an analysis of myelostimulation by bolus vs. continuous infusion of IL-1/GM-CSF. Cancer, 73, 1083-1089 (1994a).
5. BLUMENTHAL, R.D., SHARKEY, R.M., FORMAN, D., WONG, G., HESS, J. and GOLDENBERG, D.M., Improved experimental therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantation. Exp. Hematol., 23, 1088-1097 (1995a).
6. BLUMENTHAL, R.D., SHARKEY, R.M. and GOLDENBERG, D.M., Dose escalation of radioantibody in a mouse model with the use of recombinant human interleukin-1 and granulocyte-macrophage colony stimulating factor intervention to reduce myelosuppression. J. nat. Cancer Inst., 84, 399-407 (1992a).
7. BLUMENTHAL, R.D., SHARKEY, R.M. and GOLDENBERG, D.M., Overcoming dose-limiting, radioantibody-induced myelotoxicity. In: D.M. Goldenberg (ed.), Cancer therapy with radiolabeled antibodies, pp. 295-314, CRC Press, Boca Raton, FL (1995b).
8. 131I-labeled monoclonal antibodies. Cancer Res., 52,6036-6044 (1992b).
9. BLUMENTHAL, R.D., SHARKEY, R.M., NATALE, A.M., KASHI, R., WONG, G. and GOLDENBERG, D.M., Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colon cancer xenografts. Cancer Res., 54, 142-151 (1994b).
10. BRECHBIEL, M.W., GANSOW, O.A., ATCHER, R.W., SCHLOM, J., ESTEBAN, J., SIMPSON, D.E. and COLCHER, D., Synthesis of 1-(p-isothiocyanobenzyl) derivatives of DTPA and EDTA: antibody labeling and tumor imaging studies, Inorg. Chem., 25, 2772-2781 (1986).
11. BROCHUD, M.H., POTTER, M.R., MORGENSTERN, G., BLASCO. M.J., SCARFFE, J.H., THATCHER, N., CROWTHER, D., SOUZA, L.M., ALTON, N.K., TESTA, N.G. and DEXTER, T.M., In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Brit. J. Cancer, 58, 64-69 (1988).
12. BROOKS, A.L., Chromosome damage in liver cells from low dose rate alpha, beta, and gamma irradiation: deviation of RBE. Science, 190, 1090-1092 (1975).
13. 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts. Int. J. Rad. Oncol. Biol. Phys., 18, 1033-1041 (1990).
14. 131I-labeled MAbs prepared against the human milk fat globule. Cancer Res., 48, 4664-4672 (1988).
15. 2 and Fab′ in mice. Cancer Res., 46, 3969-3978(1986).
16. 131I-LYM-1 monoclonal antibodies. Int. J. Cancer (Suppl. 3), 96-101 (1988).
17. DUBOIS, A., DORVAL, E.B., STEEL, L., FIALA, N.P. and CONKLIN, J.J., Effect of ionizing radiation on prostaglandins and gastric secretion in the rhesus monkey. Rad. Res., 110, 289-293 (1987).
18. GOLDENBERG, D.M., Monoclonal antibodies in cancer detection and therapy. Amer. J. Med., 94, 297-312 (1993).
19. GOLDENBERG, D.M. and 14 OTHERS, Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J. clin. Oncol., 9, 548-564 (1991).
20. GRIFFITHS, G.L., GOLDENBERG, D.M., KNAPP, F.F., CALLAHAN, A.P., CHANG, C. H. and HANSEN, H.J., Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. Cancer Res., 51, 4594-4602 (1991).
21. HIRD, V., MARAVEYAS, A., SNOOK, D., DHOKIA, B., SOUTTER, W.P., MEARES, C., STEWART, J.S.W., MASON, P., LAMBERT, H.E. and EPENETOS, A.A., Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Brit. J. Cancer, 68, 403-406 (1993).
22. HNATOWICH, D.J., CHINOL, M., SIEBECKER, D.A., GIONET, M., GRIFFIN, T., DOHERTY, P.W., HUNTER, R. and KASE, K.R., Patient biodistribution of intraperitoneally-administered yttrium-90-labeled antibody. J. nucl. Med., 29, 1428-1435 (1988).
23. HOWELL, R.W., RAO, D.V. and SASTRY, K.S.R., Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors. Med. Phys., 16, 66-74 (1989).
24. HUI, T.E., FISHER, D.R., KUHN, J.A., WILLIAMS, J.E., NOURIGAT, C., BADGER, C.C., BEATTY, B.G. and BEATTY, J.D., A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates. Cancer, 73, 951-957 (1994).
25. HUMM, J.L., Dosimetric aspects of radiolabeled antibodies for tumor therapy. J. nucl. Med., 27, 1490-1497 (1986).
26. JUWEID, M.E., SHARKEY, R.M., BEHR, T., SWAYNE, L.C., HERSKOVIC, T., PEREIRA, M., RUBIN, A.D., HANLEY, D., DUNN, R., SIEGEL, J. and GOLDENBERG, D.M., Radioimmunotherapy of medullary thyroid cancer with I-131-labeled anti-CEA antibodies: initial results. J. nucl Med. (1997) (In press).
27. KAMINSKI, M.S., ZASADNY, K.R. and FRANCIS, I.R., Radioimmunotherapy of B-cell lymphoma with 1-131 anti-B1 (anti-CD20) antibody. New Enql. J. Med., 329, 459-165 (1993).
28. LANGMUIR, V.K. and SUTHERLAND, R.M., Radiobiology of radioimmunotherapy: current status. Antib. Immunoconj. Radiopharm., 1, 195-211 (1988).
29. LOEVINGER, R., JAPHA, E.M. and BROWNELL, G.L., Discrete radioisotope sources. In: G.L. Hine and G.L. Brownwel (eds.), p. 712, Radiation dosimetry, Academic Press, New York (1956).
30. MCCONAHEY, P.J. and DIXON, F.J., A method of trace radioiodination of proteins for immunological studies. Int. Arch. Allergy appl. lmmunol., 29, 185-189 (1966).
31. MEREDITH, R.F., KHAZAELI, M.B., LIU, T., WHEELER, R.H., RUSSELL, C., COLCHER, D., SCHLOM, J., SHOCHAT, D. and LOBUGLIO, A.F, Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer. J. nucl. Med., 33, 1648-1653 (1992).
32. MONROY, R.L., SKELLY, R.R., TAYLOR, P., DUBOIS, A., DONAHUE, R.E. and MACVITTIE, T.J., Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Exp. Hematol., 16, 344-348 (1988).
33. MOORE, M.A.S., STOFFI, R.L. and MARTIN, D.S., Hematologic effects of interleukin-1b, granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor in tumor-bearing mice treated with fluorouracil. J. nat. Cancer Inst., 82, 1031-1037 (1990).
34. 131I-CC49 in colorectal cancer. Cancer, 73 (Suppl.), 1057-1066 (1994).
35. PRESS, O.W. and 12 OTHERS, Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. New Engl. J. Med., 329, 1219-1224 (1993).
36. PRESS, O.W. and 15 OTHERS, Treatment of refractory non-Hodgkin's lymphomas with radiolabeled MB-1 (anti-CD37) antibody. J. clin. Oncol., 7, 1027-1038 (1989).
37. SAKAHARA, H., ONO, K., SAGA, T., AKUTA, K., ENDO, K., KONISHI, J. and ABE, M., Hepatocyte response to continuous low dose-rate radiation in radioimmunotherapy assessed by micronucleus assay. Int. J. Rad. Res., 62, 443-448 (1992).
38. SHARKEY, R.M. and 14 OTHERS, Clinical evaluation of tumor targeting with a high-affinity anti-carcinoembryonic antigen specific murine monoclonal antibody, MN-14. Cancer, 71, 2082-2096 (1993).
39. SHARKEY, R.M. and 12 OTHERS, Evaluation of a CDR-grafted (humanized) anti-carcinoembryonic antigen (CEA) monoclonal antibody in preclinical and clinical studies. Cancer Res., 55, 5935-5945 (1995).
40. SHIMAMURA, M., KOBAYASHI, Y., YUO, A., URABE, A., OKABE, T., KOMATSU, Y., ITOH, S. and TAKAKU, F., Effect of human recombinant granulocyte colony-stimulating factor on hematopoietic injury in mice induced by 5-fluorouracil. Blood. 69, 353-355 (1987).
41. SIEGEL, J.A. and STABIN, M.G., Absorbed fractions for electrons and beta particles in spheres of various sizes. J. nucl. Med., 35, 152-156 (1994).
42. WELTE, K., BONILLA, M.A., GILLIO, A.P., BOONE, T.C., POTTER, G.K., GABRILOVE, J.L., MOORE, M.A.S., O'REILLY, R.J. and SOUZA, L.M., Recombinant human granulocyte colony stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J. exp. Med., 165, 941-948 (1987).
43. WESSELS, B.W. and ROGUS, R.D., Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies. Med. Phys., 11, 638-645 (1984).
44. WHELDON, T.E., O'DONOGHUE, A., BARRETT, A. and MICHALOWSKI, A.S., The curability of tumours of differing size by targeted radiotherapy using I-131 or Y-90. Radiother. Oncol., 21, 91-99 (1991).
45. WITHERS, H.R. and ELKIND, M.M., Micro-colony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int. J. Rad. Biol., 17, 261-268 (1970).